Euroespes S.A. (EEP) - Total Liabilities
Based on the latest financial reports, Euroespes S.A. (EEP) has total liabilities worth €5.22 Million EUR (≈ $6.10 Million USD) as of December 2022. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Euroespes S.A. - Total Liabilities Trend (2010–2024)
This chart illustrates how Euroespes S.A.'s total liabilities have evolved over time, based on quarterly financial data. See EEP current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Euroespes S.A. Competitors by Total Liabilities
The table below lists competitors of Euroespes S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mears Group plc
LSE:MER
|
UK | GBX546.62 Million |
|
Cooper Metals Ltd
AU:CPM
|
Australia | AU$58.06K |
|
SIMFABRIC SA ZY-10
F:853
|
Germany | €1.39 Million |
|
iDimension Consolidated Bhd
KLSE:0174
|
Malaysia | RM119.71 Million |
|
Kane Biotech Inc
V:KNE
|
Canada | CA$3.48 Million |
|
Indaptus Therapeutics Inc
NASDAQ:INDP
|
USA | $6.16 Million |
|
RENFORTH RESS. INC. NEW
F:9RR
|
Germany | €690.54K |
|
International Lithium Corp
V:ILC
|
Canada | CA$306.66K |
Liability Composition Analysis (2010–2024)
This chart breaks down Euroespes S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Euroespes S.A. market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.38 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.84 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Euroespes S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Euroespes S.A. (2010–2024)
The table below shows the annual total liabilities of Euroespes S.A. from 2010 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €4.37 Million ≈ $5.11 Million |
-13.27% |
| 2023-12-31 | €5.04 Million ≈ $5.89 Million |
-3.41% |
| 2022-12-31 | €5.22 Million ≈ $6.10 Million |
+8.20% |
| 2021-12-31 | €4.82 Million ≈ $5.64 Million |
+13.31% |
| 2020-12-31 | €4.26 Million ≈ $4.98 Million |
+8.50% |
| 2019-12-31 | €3.92 Million ≈ $4.59 Million |
-0.94% |
| 2018-12-31 | €3.96 Million ≈ $4.63 Million |
-17.11% |
| 2017-12-31 | €4.78 Million ≈ $5.59 Million |
+3.13% |
| 2016-12-31 | €4.63 Million ≈ $5.42 Million |
+26.95% |
| 2015-12-31 | €3.65 Million ≈ $4.27 Million |
+1.71% |
| 2014-12-31 | €3.59 Million ≈ $4.20 Million |
+218.29% |
| 2010-12-31 | €1.13 Million ≈ $1.32 Million |
-- |
About Euroespes S.A.
Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally. It offers personalized and genomic medicine services for predictive, diagnostic, and therapeutic purposes. The company also provides medical services, such as neuro-ophthalmology, neuro-otorhinolaryngology, neu… Read more